Keyphrases
Age Groups
100%
Cognitive Function
100%
Hormone Therapy
100%
Cognitive Trajectory
100%
Menopausal Hormone Therapy
100%
Conjugated Equine Estrogens
100%
Hysterectomy
66%
Older Women
66%
Menopause
33%
Working Memory
33%
Cognitive Domains
33%
Placebo
33%
Therapy Regimen
33%
Executive Function
33%
Active Intervention
33%
Randomized Controlled Clinical Trial
33%
Intervention Effect
33%
Cognitive Assessment
33%
Women Age
33%
Women's Health Initiative
33%
Cognitive Benefits
33%
Medroxyprogesterone Acetate
33%
Post-intervention Follow-up
33%
Global Cognitive Function
33%
Last Menstrual Period
33%
Medicine and Dentistry
Hormone Therapy
100%
Cognition
80%
Ethinylestradiol
60%
Patient History of Hysterectomy
40%
Drug Therapy
20%
Executive Function
20%
Menstrual Cycle
20%
Medroxyprogesterone Acetate
20%
Controlled Clinical Trial
20%
Women's Health
20%
Working Memory
20%
Cognitive Assessment
20%
Placebo
20%
Depo-Provera
20%
Nursing and Health Professions
Hormonal Therapy
100%
Premarin
60%
Ethinylestradiol
60%
Patient History of Hysterectomy
40%
Drug Therapy
20%
Placebo
20%
Medroxyprogesterone Acetate
20%
Neuroscience
Hormone Therapy
100%
Cognitive Function
80%
Premarin
60%
Depo-Provera
20%
Placebo
20%
Working Memory
20%
Executive Function
20%
Pharmacology, Toxicology and Pharmaceutical Science
Endocrine Therapy
100%
Conjugated Estrogen
60%
Ethinylestradiol
60%
Patient History of Hysterectomy
40%
Controlled Clinical Trial
20%
Placebo
20%
Medroxyprogesterone Acetate
20%